Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue
Submit an article Journal homepage
518
Views
14
CrossRef citations to date
0
Altmetric
Review

Autosomal dominant polycystic kidney disease: updated perspectives

Anjay Rastogi1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
,
Khalid Mohammed Ameen1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
,
Maha Al-Baghdadi1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
,
Kelly Shaffer1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
,
Niloofar Nobakht1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
,
Mohammad Kamgar1 Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA
&
Edgar V Lerma2 Department of Medicine, Divison of Nephrology, University of Illinois at Chicago/Advocate Christ Medical Center, Section of Nephrology, Oak Lawn, IL, USACorrespondence[email protected]
 show all
Pages 1041-1052 | Published online: 26 Aug 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Philippe Nuss, Emmanuelle Corruble, Emmanuelle Baloche, Ricardo P. Garay & Pierre-Michel Llorca. (2022) Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond. Expert Review of Neurotherapeutics 22:8, pages 639-653.
Read now
Ioannis Bellos. (2021) Safety Profile of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease. Therapeutics and Clinical Risk Management 17, pages 649-656.
Read now

Articles from other publishers (12)

Feng Wang, Seo Yeon Lee, Fatemeh Adelnia, Keiko Takahashi, Kevin D. Harkins, Lilly He, Zhongliang Zu, Philipp Ellinger, Manuel Grundmann, Raymond C. Harris, Takamune Takahashi & John C. Gore. (2023) Severity of polycystic kidney disease revealed by multiparametric MRI . Magnetic Resonance in Medicine.
Crossref
Hisashi Murakami, Satoshi Okubo, Masahiro Kobayashi, Miho Akabane, Masaru Matsumura, Junichi Shindoh & Masaji Hashimoto. (2022) Gallbladder cancer concomitant with autosomal dominant polycystic kidney disease: A case report. Clinical Case Reports 10:12.
Crossref
Arjun Sekar. (2022) Marfan Syndrome and Autosomal Dominant Polycystic Kidney Disease: A Case of Rare Co-occurrence or Coincidence?. European Medical Journal, pages 94-98.
Crossref
Masaw Akbari, Jonathan D. West, Nicholas Doerr, Kevin R. Kipp, Neda Marhamati, Sabrina Vuong, Yidi Wang, Markus M. Rinschen, Jeffrey J. Talbot, Oliver Wessely & Thomas Weimbs. (2022) Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression. Proceedings of the National Academy of Sciences 119:30.
Crossref
Fazle Rabbi, Sajjad Rahmani Dabbagh, Pelin Angin, Ali Kemal Yetisen & Savas Tasoglu. (2022) Deep Learning-Enabled Technologies for Bioimage Analysis. Micromachines 13:2, pages 260.
Crossref
Eder Aldair Vera-Quintanilla & Catalina del Rosario García-Ramírez. (2022) Transformación poliquística de riñón trasplantado. Revista Mexicana de Trasplantes 11:3, pages 107-111.
Crossref
艾琳 杜. (2022) Progress in the Diagnosis and Treatment of Traditional Chinese Medicine and Western Medicine for Autosomal Dominant Polycystic Kidney Disease. Advances in Clinical Medicine 12:09, pages 8487-8492.
Crossref
Dakota Philo. (2021) Horseshoe Kidney in Conjunction With Autosomal Dominant Polycystic Kidney Disease: A Case Report. Journal of Diagnostic Medical Sonography 37:3, pages 298-303.
Crossref
Hao Shi, Wenbin Niu, Yidong Liu, Haixia Jin, Wenyan Song, Senlin Shi, Guidong Yao, Jiawei Xu & Yingpu Sun. (2020) A novel monogenic preimplantation genetic testing strategy for sporadic polycystic kidney caused by de novo PKD1 mutation . Clinical Genetics 99:2, pages 250-258.
Crossref
Parvathi Perumareddi & Darin P. Trelka. (2020) Autosomal Dominant Polycystic Kidney Disease. Primary Care: Clinics in Office Practice 47:4, pages 673-689.
Crossref
Chigozie G. Uko. (2020) Recognizing and treating autosomal dominant polycystic kidney disease. The Nurse Practitioner 45:11, pages 41-47.
Crossref
Niloofar Nobakht, Ramy M. Hanna, Maha Al-Baghdadi, Khalid Mohammed Ameen, Farid Arman, Ehsan Nobahkt, Mohammad Kamgar & Anjay Rastogi. (2020) Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review. Kidney Medicine 2:2, pages 196-208.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.